One of the biggest threats to a company's focus is a bored founder. Convinced of their own intelligence, they chase new, shiny opportunities, which dilutes resources and distracts from the core mission that made them successful in the first place.

A founder's revenue was flat until he abandoned the side project he thought was his future "big idea" (his ego business) and went all-in on the business that already had momentum. The company's revenue then tripled within six months of this decision.

It's tempting to add adjacent revenue streams like training or job boards. However, these often represent entirely new business models requiring different organizational commitments, potentially distracting you from perfecting your primary revenue engine.

As companies grow and add new product lines or target new segments, their once-sharp positioning becomes diluted. This happens because product marketing resources are not scaled to support each new business unit, ICP, and segment, leading to generic, ineffective messaging.

A founder can only excel at one function at a time. In the beginning, it's product. Once that's solid, the focus must shift entirely to go-to-market and founder-led sales. Later, it may become finance. This is a conscious trade-off and sequential juggling act.

The founder of Randomals was tempted by animation deals while struggling with inventory. The advice was to ignore these 'sexy' but distracting opportunities. True scale comes from disciplined focus on strengthening the supply chain and mastering the single sales channel that's already proven successful, not from chasing scattershot growth.

A common failure mode for well-funded biotechs is growing headcount too rapidly. Immunocore's CEO advises new leaders to pace themselves, emphasizing that drug development is a marathon. Prematurely scaling creates fixed expenses that can drain capital before key scientific milestones are hit.

Pivoting isn't just for failing startups; it's a requirement for massive success. Ambitious companies often face 're-founding moments' when their initial product, even if successful, proves insufficient for market-defining scale. This may require risky moves, like competing against your own customers.

Even a company with significant revenue can be stuck in the "problem-market fit" stage if it introduces too much complexity. Pursuing multiple products, ICPs, or go-to-market motions dilutes focus and exponentially increases difficulty, hindering the ability to scale effectively.